276 related articles for article (PubMed ID: 18238789)
1. Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.
Tynjälä P; Kotaniemi K; Lindahl P; Latva K; Aalto K; Honkanen V; Lahdenne P
Rheumatology (Oxford); 2008 Mar; 47(3):339-44. PubMed ID: 18238789
[TBL] [Abstract][Full Text] [Related]
2. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.
Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K
Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061
[TBL] [Abstract][Full Text] [Related]
3. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
Quartier P; Baptiste A; Despert V; Allain-Launay E; Koné-Paut I; Belot A; Kodjikian L; Monnet D; Weber M; Elie C; Bodaghi B;
Ann Rheum Dis; 2018 Jul; 77(7):1003-1011. PubMed ID: 29275333
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
Zannin ME; Birolo C; Gerloni VM; Miserocchi E; Pontikaki I; Paroli MP; Bracaglia C; Shardlow A; Parentin F; Cimaz R; Simonini G; Falcini F; Corona F; Viola S; De Marco R; Breda L; La Torre F; Vittadello F; Martini G; Zulian F
J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Foeldvari I; Nielsen S; Kümmerle-Deschner J; Espada G; Horneff G; Bica B; Olivieri AN; Wierk A; Saurenmann RK
J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab).
Heiligenhaus A; Miserocchi E; Heinz C; Gerloni V; Kotaniemi K
Rheumatology (Oxford); 2011 Aug; 50(8):1390-4. PubMed ID: 21378109
[TBL] [Abstract][Full Text] [Related]
7. Use of adalimumab in refractory non-infectious childhood chronic uveitis: efficacy in ocular disease--a case cohort interventional study.
Sen ES; Sharma S; Hinchcliffe A; Dick AD; Ramanan AV
Rheumatology (Oxford); 2012 Dec; 51(12):2199-203. PubMed ID: 22923752
[TBL] [Abstract][Full Text] [Related]
8. Experiences with tumour necrosis factor-{alpha} inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry.
Sevcic K; Orban I; Brodszky V; Bazso A; Balogh Z; Poor G; Kiss E
Rheumatology (Oxford); 2011 Jul; 50(7):1337-40. PubMed ID: 21372001
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF
Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab for juvenile idiopathic arthritis-associated uveitis.
Magli A; Forte R; Navarro P; Russo G; Orlando F; Latanza L; Alessio M
Graefes Arch Clin Exp Ophthalmol; 2013 Jun; 251(6):1601-6. PubMed ID: 23446556
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis.
Trachana M; Pratsidou-Gertsi P; Pardalos G; Kozeis N; Badouraki M; Kanakoudi-Tsakalidou F
Scand J Rheumatol; 2011 Mar; 40(2):101-7. PubMed ID: 21108543
[TBL] [Abstract][Full Text] [Related]
12. Chronic uveitis in children with and without juvenile idiopathic arthritis: differences in patient characteristics and clinical course.
Heinz C; Mingels A; Goebel C; Fuchsluger T; Heiligenhaus A
J Rheumatol; 2008 Jul; 35(7):1403-7. PubMed ID: 18484686
[TBL] [Abstract][Full Text] [Related]
13. Adalimumab in the therapy of uveitis in childhood.
Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M
Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274
[TBL] [Abstract][Full Text] [Related]
14. Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis.
Tappeiner C; Heinz C; Roesel M; Heiligenhaus A
Acta Ophthalmol; 2011 Sep; 89(6):e521-7. PubMed ID: 21586097
[TBL] [Abstract][Full Text] [Related]
15. Etanercept and uveitis in patients with juvenile idiopathic arthritis.
Schmeling H; Horneff G
Rheumatology (Oxford); 2005 Aug; 44(8):1008-11. PubMed ID: 15855187
[TBL] [Abstract][Full Text] [Related]
16. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
Kump LI; Castañeda RA; Androudi SN; Reed GF; Foster CS
Ophthalmology; 2006 Oct; 113(10):1874-7. PubMed ID: 16884776
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.
Lovell DJ; Ruperto N; Goodman S; Reiff A; Jung L; Jarosova K; Nemcova D; Mouy R; Sandborg C; Bohnsack J; Elewaut D; Foeldvari I; Gerloni V; Rovensky J; Minden K; Vehe RK; Weiner LW; Horneff G; Huppertz HI; Olson NY; Medich JR; Carcereri-De-Prati R; McIlraith MJ; Giannini EH; Martini A; ;
N Engl J Med; 2008 Aug; 359(8):810-20. PubMed ID: 18716298
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
Colombel JF; Sandborn WJ; Rutgeerts P; Kamm MA; Yu AP; Wu EQ; Pollack PF; Lomax KG; Chao J; Mulani PM
Am J Gastroenterol; 2009 May; 104(5):1170-9. PubMed ID: 19352339
[TBL] [Abstract][Full Text] [Related]
19. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients.
Kotaniemi K; Arkela-Kautiainen M; Haapasaari J; Leirisalo-Repo M
Ann Rheum Dis; 2005 Jun; 64(6):871-4. PubMed ID: 15897307
[TBL] [Abstract][Full Text] [Related]
20. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab.
Simonini G; Taddio A; Cattalini M; Caputo R; De Libero C; Naviglio S; Bresci C; Lorusso M; Lepore L; Cimaz R
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):612-8. PubMed ID: 21452272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
